FDA Inspection
Staska Pharmaceuticals, Inc.Staska Pharmaceuticals, Inc. – FDA Inspection, Feb 20, 2026
Record Details
This FDA Inspection record concerns Staska Pharmaceuticals, Inc., with an inspection on February 20, 2026, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · 98351a0f-62de-4229-a79d-6603afa06f3c
Inspection Facts
- Inspection number
- 1304594
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Staska Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2024 | OAI | Kansas City District Office | Drug Quality Assurance |
Other documents for Staska Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.